Sterling Pharma Solutions
Information
Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years' experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling has four facilities employing more than 800 people. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.
Exhibitor Access Type
In-person & Online
Sub-event
CPhI
Country
[object Object]
Organization Type
Manufacturer/Innovator
Markets Active In
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countries
Booth Location
7H51
Offering
Offering: Products or Services
Custom ManufacturingIntermediates, Fine and Specialty ChemicalsContract Services
Offering: Contract Services
ChromatographyMethod DevelopmentMethod ValidationQuality Control TestingStability TestingAnalytical DevelopmentContract ManufacturingDevelopment & Validation of Analytical MethodsDrug DiscoveryProcess OptimisationSynthetic Organic ChemistrySynthetic Route DesignChemical synthesis/analysis
Offering: Custom Manufacturing
API Contract ManufacturingExclusive Synthesis of APIsCustom Manufacturing (general category)Custom Manufacturing/Exclusive Synthesis of Fine Chemicals
Offering: Intermediates, Fine and Specialty Chemicals
Advanced IntermediatesChiral Intermediates
